Core Laboratories
CLB
283 hedge funds and large institutions have $1.76B invested in Core Laboratories in 2019 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 98 increasing their positions, 84 reducing their positions, and 39 closing their positions.
73% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $7.6M
49% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 39
17% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 84
3% more funds holding
Funds holding: 274 → 283 (+9)
3.23% less ownership
Funds ownership: 108.62% → 105.39% (-3.2%)
21% less capital invested
Capital invested by funds: $2.23B → $1.76B (-$465M)
Top Buyers
| 1 |
VanEck Associates
New York
|
+$30.5M |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
+$27.6M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$22.9M |
| 4 |
CPH
C Partners Holding
Zurich,
Switzerland
|
+$12.7M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$12.2M |
Top Sellers
CLB Hedge Fund Activity: Q4 2019 in Review
283 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2019, worth a combined $1.76B — down 21% from $2.23B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new CLB positions and 39 closed out — a net gain of 19 holders — while 98 added to existing stakes and 84 trimmed.
The largest buyer was VanEck Associates, adding an estimated $30.5M. The largest seller was ClearBridge Investments, cutting an estimated $56.4M.
- 283 institutional investors held Core Laboratories (CLB) as of Q4 2019, up from 274 in Q3 2019.
- Funds reported $1.76B of Core Laboratories stock for Q4 2019, down 21% quarter-over-quarter.
- 58 funds opened new Core Laboratories positions in Q4 2019 and 39 closed out, a net change of +19 holders.
- The largest Core Laboratories buyer in Q4 2019 was VanEck Associates, an estimated $30.5M added.
- The largest Core Laboratories seller in Q4 2019 was ClearBridge Investments, an estimated $56.4M sold.
Based on aggregated 13F filings for Q4 2019.